Monday, June 27, 2022

A Look at the Most Common Neurodegenerative Diseases

nytimes.com
NTL Group's head of research and development, Dr. Curtis Cripe, is committed to neuroscience. He has even gone the extra mile, writing about his work in hopes of sharing his knowledge and expertise with readers everywhere.

For this post, Dr. Curtis Cripe shares his knowledge of neurodegenerative diseases and discusses some of the most common types.

Neurodegenerative disease is a chronic progressive condition that results in the deterioration and death of nerve cells in the brain or other parts of the nervous system. This leads to a decline in cognitive function, mobility, and different abilities. Neurodegenerative diseases are incurable and often result in death.

There are many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, Huntington's disease, and amyotrophic lateral sclerosis (ALS). Each type of neurodegenerative disease has its unique symptoms and progression.
medicalnewstoday.com 

Alzheimer's disease, known as Alzheimer's, is the most common type of neurodegenerative disease. It affects millions of people worldwide and is the leading cause of dementia. Parkinson's disease is the second most common neurodegenerative disease. It affects about a million people in the United States and is the leading cause of disability in older adults. Huntington's disease is a rare neurodegenerative disease that typically affects people in mid-life. Finally, ALS is a rare neurodegenerative disease that affects nerve cells in the brain and spinal cord.

There is no known cure for any neurodegenerative disease. However, treatments are available to help manage symptoms and slow the progression of the disease. Treatment options for neurodegenerative diseases vary depending on the type of neurodegenerative disease.

If you or someone you love has been diagnosed with a neurodegenerative disease, Dr. Curtis Cripe says it is important to stay positive and seek out all available resources. With support, information, and treatment, it's possible to live a full and rewarding life despite the challenges posed by these diseases.

Dr. Curtis Cripe is the director of the NTL Group’s research and development team. For more information, click on this link.